Companies covered:
Bouchey
Abgenix, Inc.1 ABGX
M. Perform/Buy 18
Allos Therapeutic1 ALTH
Buy/Buy 19
Angiotech Pharma.1 ANPI
Buy/Buy 64
Boston Scientific BSX
Buy/Buy 44
Gilead Sciences1 GILD
Buy/Buy 40
Isis Pharmaceuticals1 ISIS
Avoid/M. Perform NA
MGI Pharma.1 MOGN
M. Perform/M. Perform NA
Northwest Bio.1,2 NWBT
Buy/Buy 10
Trbovich
Acambis Plc1 ACAM
Buy/Buy 50
Cellegy Pharma.1,3,4 CLGY
Avoid/M. Perform NA
Connetics Corp.1 CNCT
Buy/Buy 13
ICOS Corp.1 ICOS
Buy/Buy 28
Medicis Pharma. MRX
Buy/Buy 65
Novavax Inc.1 NVAX
M. Perform/M. Perform NA
Noven Pharma.1 NOVN
M. Perform/M. Perform NA
Strategic Diagnostics1
SDIX M. Perform/M. Perform NA
Vivus Inc.1
VVUS Buy/Buy 12
Women First HeathCare, Inc.1 WFHC
Buy/Buy 10
Onyx Pharma.1 ONXX
M. Perform/M. Perform NA
OSI Pharma.1,3 OSIP
Buy/Buy 46
Pharmacyclics, Inc.1 PCYC
M. Perform/Buy 10
Protein Design Labs1 PDLI
M. Perform/Buy 26
Triangle Pharma.1 VIRS
M. Perform/M. Perform NA
Trimeris1 TRMS
M. Perform/Buy 57
DISCLAIMERS
1. C.E. Unterberg, Towbin makes a market in this security.
2. C.E. Unterberg, Towbin acted as a manager or co-manager of a public offering for this company within the last three years.
3. C.E. Unterberg, Towbin has performed investment banking, capital markets or other services for this company within the last three years.
4. Securities, or derivatives thereof, of this company are owned either directly by the securities analyst covering the stock, a member of his or her team, or indirectly by the household family members.
5. An officer, or a household family member of an officer, of C.E. Unterberg, Towbin, is a director or an officer of this company. |
